pubmed-article:19720919 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C1556084 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0040715 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C2349984 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C1522702 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0599718 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0599813 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0599893 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0681804 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:19720919 | lifeskim:mentions | umls-concept:C0439858 | lld:lifeskim |
pubmed-article:19720919 | pubmed:issue | 28 | lld:pubmed |
pubmed-article:19720919 | pubmed:dateCreated | 2009-9-30 | lld:pubmed |
pubmed-article:19720919 | pubmed:abstractText | Acute myeloid leukemia (AML) with translocation (t) (8;21) or inversion (inv) (16) is associated with a favorable prognosis when treated with intensive chemotherapy. In elderly patients, these AML types are rare, and intensive treatments are much less tolerated. We conducted a retrospective study to evaluate the characteristics and outcome of AML with t(8;21) or inv(16) in the elderly. | lld:pubmed |
pubmed-article:19720919 | pubmed:language | eng | lld:pubmed |
pubmed-article:19720919 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19720919 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19720919 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19720919 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19720919 | pubmed:month | Oct | lld:pubmed |
pubmed-article:19720919 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:GuilhotFranço... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:VeyNorbertN | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:QuesnelBrunoB | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:UgoValérieV | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:PigneuxArnaud... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:RecherChristi... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:ThomasXavierX | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:DombretHervéH | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:WitzFrancisF | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:CastaigneSylv... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:CahnJean-Yves... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:BoisselNicola... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:HunaultMathil... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:TavernierEmma... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:DelaunayJacqu... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:Acute... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:TerreChristin... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:PrébetThomasT | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:EsterniBenjam... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:ReutenauerSar... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:ThépotSylvain... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:Groupe... | lld:pubmed |
pubmed-article:19720919 | pubmed:author | pubmed-author:Core... | lld:pubmed |
pubmed-article:19720919 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19720919 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19720919 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:19720919 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19720919 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19720919 | pubmed:pagination | 4747-53 | lld:pubmed |
pubmed-article:19720919 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:meshHeading | pubmed-meshheading:19720919... | lld:pubmed |
pubmed-article:19720919 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19720919 | pubmed:articleTitle | Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. | lld:pubmed |
pubmed-article:19720919 | pubmed:affiliation | Institut Paoli-Calmettes, 13009 Marseille, France. | lld:pubmed |
pubmed-article:19720919 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19720919 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19720919 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19720919 | lld:pubmed |